Imaging Can Identify Breast Cancer Subtypes
(Ivanhoe Newswire) –An optical imaging technique that measures metabolic activity in cancer cells can accurately differentiate breast cancer subtypes. It can also detect responses to treatment as early as two days after therapy administration, according to a recent study at Vanderbilt University.
“We have shown that optical metabolic imaging (OMI) enables fast, sensitive, and accurate measurement of drug action. Importantly, OMI measurements can be made repeatedly over time in a live animal, which significantly reduces the cost of these preclinical studies,” Alex Walsh, a graduate student in the Department of Biomedical Engineering at Vanderbilt University in Nashville, Tenn., was quoted as saying.
Researchers say that OMI can be used on tissues freshly excised from patients but, with further development, it could be incorporated in endoscopes for live imaging of human cancers.
For more information, go to: http://www.aacr.org/home/public--media/aacr-in-the-news.aspx?d=3179
SOURCE: Cancer Research, October 2013
Click Here for a free weekly email with Ivanhoe's latest Medical Breakthroughs.